Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIII.

Russell AL, Prince C, Lundgren TS, Knight KA, Denning G, Alexander JS, Zoine JT, Spencer HT, Chandrakasan S, Doering CB

Open source

DOI
10.1016/j.omtm.2021.04.016
Published
2021 Jun 11
Container
Molecular therapy. Methods & clinical development
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtm.2021.04.016,
  title = {Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIII.},
  author = {Russell AL and Prince C and Lundgren TS and Knight KA and Denning G and Alexander JS and Zoine JT and Spencer HT and Chandrakasan S and Doering CB},
  year = {2021},
  journal = {Molecular therapy. Methods \& clinical development},
  doi = {10.1016/j.omtm.2021.04.016},
  url = {https://doi.org/10.1016/j.omtm.2021.04.016}
}

RIS

TY  - JOUR
TI  - Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIII.
AU  - Russell AL
AU  - Prince C
AU  - Lundgren TS
AU  - Knight KA
AU  - Denning G
AU  - Alexander JS
AU  - Zoine JT
AU  - Spencer HT
AU  - Chandrakasan S
AU  - Doering CB
PY  - 2021
JO  - Molecular therapy. Methods & clinical development
DO  - 10.1016/j.omtm.2021.04.016
UR  - https://doi.org/10.1016/j.omtm.2021.04.016
ER  - 

APA

AL, R., C, P., TS, L., KA, K., G, D., JS, A., JT, Z., HT, S., S, C., & CB, D. (2021). Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIII.. Molecular therapy. Methods & clinical development. https://doi.org/10.1016/j.omtm.2021.04.016

Source records